Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Lynne Cox of the Department of Biochemistry will co-lead a new national research network focused on transforming the health of older people and boosting the economy.

Pipette and test tubes

The BLAST (Building Links in Ageing Science and Translation) network brings together researchers from across the country to increase our understanding of how the ageing process causes illness and impairment in later life. It will inform the nationwide research agenda for the development of new tools and interventions to help people stay healthy as they grow old and treat conditions for which little can be done today.

Potential new developments include treatments aimed at removing or modifying senescent cells, which are known to drive ageing pathology. Identifying markers of ageing biology that can detect changes before the onset of illness, and that can be used to monitor the effectiveness of early treatments, is also a priority. The network will also look at regenerative approaches to improving health.

Breakthroughs such as these would greatly increase older people’s quality of life in the UK and have a significant impact on national productivity and wealth. Research in the USA, for example, found that adding just one year to healthy life expectancy would add trillions of dollars to the US economy. Similar savings are possible for the UK, with the new research placing the UK at the forefront of a burgeoning new biotech industry.

Read the full story on the University of Oxford website

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.